Drug
Sepiapterin
Sepiapterin: highest development phase Phase 3, developed by PTC Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sepiapterin NCT06302348 | Phase 3 | Phenylketonuria |
Latest
No recent events.
Follow Sepiapterin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.